Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. WBRT

   United Therapeutics Europe Ltd

   Bladder Cancer

   phase 2 · other · active

   1 trial →

2. WO39608

   Hoffmann-La Roche

   Pancreatic ductal adenocarcinoma (PDAC)

   phase 2 · small molecule · active

   1 trial →

3. WO42178

   Hoffmann-La Roche

   Persistent or Recurrent Rare Epithelial Ovarian Tumors

   phase 2 · small molecule · active

   1 trial →

4. WO46063

   Hoffmann-La Roche

   Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha gene (PIK3CA)-Mutated, hormone receptor-positive (HR-Positive), human epidermal growth factor receptor 2 (HER2)-Negative Locally Advanced or Metastatic Breast Cancer

   phase 2 · small molecule · active

   1 trial →

5. WSD0922-FU, WSD0922-FU

   Alphapharm Pty Ltd

   Non-Small Cell Lung Cancer

   phase 2 · small molecule · active

   1 trial →

6. WTX-330

   Werewolf Therapeutics

   Advanced or Metastatic Solid Tumors

   phase 2 · small molecule · active

   2 trials →

7. Watchful waiting, RO7198457 (autogene cevumeran)

   BioNTech SE

   Stage II/Stage III rectal cancer or Stage II (high risk)/Stage III colon cancer

   phase 2 · small molecule · active

   1 trial →

8. Will receive HH-009 injection 20 mg/kg, Q3W

   Huahui Health

   Advanced or Unresectable Hepatocellular Carcinoma (HCC)

   phase 2 · small molecule · active

   1 trial →

9. X4P-001

   X4 Pharmaceuticals, Inc

   Clear Cell Renal Cell Carcinoma

   phase 2 · small molecule · completed

   2 trials →

10. XB2001 or Placebo

    XBiotech Germany GmbH

    Pancreatic Cancer

    phase 2 · mab · active

    1 trial →

11. XELOX combined with Fruquintinib and Sintilimab

    The First People's Hospital of Lianyungang

    Gastric Cancer/Gastroesophageal Junction Adenocarcinoma

    phase 2 · small molecule · active

    1 trial →

12. XMDYYYXYK-04

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 2 · small molecule · active

    1 trial →

13. XTX202

    Xilio Therapeutics

    Advanced Solid Tumor

    phase 2 · small molecule · completed

    1 trial →

14. XTX301

    Xilio Therapeutics

    Advanced Solid Tumor

    phase 2 · small molecule · active

    1 trial →

15. Xospata 40 mg film-coated tablets

    Fondazione Telethon ETS

    newly diagnosed non-M3 FLT3-positive acute myeloid leukemia

    phase 2 · small molecule · active

    1 trial →

16. YERVOY for castration-resistant prostate c…

    Disc Medicine

    castration-resistant prostate cancer

    phase 2 · small molecule · active

    1 trial →

17. Z650

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Esophageal Squamous Cell Carcinoma

    phase 2 · small molecule · completed

    1 trial →

18. ZD6474

    United Therapeutics Europe Ltd

    Lung Cancer

    phase 2 · small molecule · completed

    2 trials →

19. ZG005

    Suzhou Zelgen Biopharmaceuticals Co.,Ltd

    Biliary Tract Carcinoma

    phase 2 · small molecule · active

    1 trial →

20. ZIMBERELIMAB

    Arcus Biosciences

    Pancreatic Cancer

    phase 2 · small molecule · on hold

    1 trial →

21. ZIO-201

    Alaunos Therapeutics

    Advanced Sarcoma

    phase 2 · small molecule · completed

    1 trial →

22. ZIV-Aflibercept

    Regeneron UK Limited

    Metastatic Uveal Melanoma

    phase 2 · small molecule · active

    1 trial →

23. ZN-d5 ZN-c3

    Zentalis Pharmaceuticals

    Acute Myeloid Leukemia (AML)

    phase 2 · small molecule · terminated

    1 trial →

24. ZW25 (Zanidatamab)

    Jazz Pharmaceuticals Ireland Limited

    HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

    phase 2 · small molecule · completed

    1 trial →

25. ZW25 (Zanidatamab)

    BEONE MEDICINES AUS PTY LTD

    HER2-amplified Biliary Tract Cancers

    phase 2 · small molecule · completed

    1 trial →

26. ZW25 (Zanidatamab)

    Jazz Pharmaceuticals Ireland Limited

    HER2+/HR+ Breast Cancer

    phase 2 · small molecule · completed

    1 trial →

27. ZWI-ZW25-202

    Jazz Pharmaceuticals Ireland Limited

    Breast cancer patients including those with locally advanced (unresectable) or metastatic HER2-positive, HR-positive breast cancer

    phase 2 · small molecule · active

    1 trial →

28. ZZ-IT-ICI-HCC 1line-023

    Second Affiliated Hospital of Soochow University

    Liver Cancer

    phase 2 · small molecule · active

    1 trial →

29. Zanidatamab

    Jazz Pharmaceuticals Ireland Limited

    Non-Small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

30. Zanidatamab

    Jazz Pharmaceuticals Ireland Limited

    HER2-positive Breast Cancer

    phase 2 · small molecule · active

    1 trial →

31. Zanidatamab

    Jazz Pharmaceuticals Ireland Limited

    Breast Cancer

    phase 2 · small molecule · active

    1 trial →

32. Zanidatamab

    Jazz Pharmaceuticals Ireland Limited

    Gastroesophageal Adenocarcinoma

    phase 2 · small molecule · active

    1 trial →

33. Zanidatamab

    ALX ONCOLOGY HOLDINGS INC

    HER2-expressing Cancers

    phase 2 · small molecule · completed

    1 trial →

34. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    Relapsed/Refractory Follicular Non-Hodgkin Lymphoma

    phase 2 · small molecule · completed

    1 trial →

35. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    Mantle Cell Lymphoma

    phase 2 · small molecule · active

    1 trial →

36. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    Follicular Lymphoma

    phase 2 · small molecule · active

    1 trial →

37. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    Diffuse Large B-cell Lymphoma (DLBCL)

    phase 2 · small molecule · active

    1 trial →

38. Zanubrutinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Mantle Cell Lymphoma

    phase 2 · small molecule · active

    1 trial →

39. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    phase 2 · small molecule · completed

    1 trial →

40. Zanubrutinib

    The First People's Hospital of Lianyungang

    Non Hodgkin Lymphoma

    phase 2 · small molecule · active

    1 trial →

41. Zanubrutinib

    The First People's Hospital of Lianyungang

    Chronic Lymphocytic Leukemia

    phase 2 · small molecule · active

    1 trial →

42. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    Relapsed Diffuse Large B-cell Lymphoma

    phase 2 · small molecule · completed

    1 trial →

43. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    Chronic Lymphocytic Leukemia (CLL)

    phase 2 · small molecule · active

    1 trial →

44. Zanubrutinib+Rituximab+Lenalidomide

    The First People's Hospital of Lianyungang

    Diffuse Large B Cell Lymphoma

    phase 2 · small molecule · active

    1 trial →

45. Zelenectide Pevedotin, BT8009

    BICYCLE THERAPEUTICS

    Advanced or Metastatic Non-small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

46. Zentalis

    Zentalis Pharmaceuticals

    Advanced Pancreatic Adenocarcinoma

    phase 2 · small molecule · active

    1 trial →

47. Ziftomenib

    Kura Oncology

    Advanced Malignant Neoplasm

    phase 2 · small molecule · active

    1 trial →

48. Ziftomenib, Ziftomenib

    Kura Oncology

    Relapsed and/or refractory Acute Myeloid Leukemia

    phase 2 · small molecule · active

    1 trial →

Frequently asked questions